Man Arrested on Federal Charges of Selling Fake Pills that caused Fatal Fentanyl Overdose
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Man Arrested on Federal Charges of Selling Fake Pills that caused Fatal Fentanyl Overdose

Man Arrested on Federal Charges of Selling Fake Pills that caused Fatal Fentanyl Overdose

August 01, 2022
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Rosa Valle-Lopez
Phone Number: (571) 387-5045

Arrested picture with handcuffs
Arrested Generic Pic.jpg

LOS ANGELES – A Paso Robles man has been arrested on federal charges of selling counterfeit prescription pills containing fentanyl to a 19-year-old Atascadero resident who suffered a fatal overdose from the synthetic opioid, the Justice Department announced today.

Timothy Clark Wolfe, 24, was taken into custody Thursday by special agents with the Drug Enforcement Administration, and he was arraigned on the federal charges this afternoon in United States District Court in downtown Los Angeles.

A federal grand jury on July 19 charged Wolfe in a two-count indictment that accuses him of distributing fentanyl resulting in death and possession with the intent to distribute alprazolam (often sold under the brand name Xanax).

Wolfe pleaded not guilty to the charges in the indictment and a September 20 trial date was scheduled. A federal magistrate judge ordered Wolfe released on $150,000 bond.

The indictment alleges that, on March 8, 2020, Wolfe sold the victim the fentanyl-laced pills, “the use of which resulted in the death and serious bodily injury of E.V.”

During a search of Wolfe’s residence the following day after the death of E.V., Atascadero Police discovered the alprazolam, which the indictment alleges he intended to distribute.

 The San Luis Obispo County District Attorney’s Office charged Wolfe in relation to the overdose death on May 20, 2020. The District Attorney’s Office will dismiss their state charges in light of the federal prosecution. 

An indictment contains allegations that a defendant has committed a crime. Every defendant is presumed innocent until and unless proven guilty beyond a reasonable doubt.

The charge of distributing fentanyl resulting in death carries a mandatory minimum sentence of 20 years in federal prison and a maximum statutory penalty of life. The charge of possession with the intent to distribute alprazolam carries a maximum statutory penalty of five years in federal prison.

The DEA’s Los Angeles Field Office is investigating this matter. The Atascadero Police Department and the San Luis Obispo County District Attorney’s Office provided substantial assistance.

Assistant United States Attorneys Julia Hu of the Major Frauds Section and Jena MacCabe of the General Crimes Section are prosecuting this case.

The Centers for Disease Control and Prevention estimates that 108,642 people died as the result of a drug overdose in the United States during the one-year period ending February 2022. Synthetic opioids, such as fentanyl and its analogs, are the primary driver of the increase in drug overdose deaths. Synthetic opioids are involved in 67% of all drug overdose deaths and 89% of opioid-involved drug overdose deaths.

According to the DEA, criminal drug networks in Mexico are mass-producing illicit fentanyl and fake pills pressed with fentanyl in clandestine, unregulated labs. These fake pills are designed to look like real prescription pills, typically replicating prescription opioid medications such as oxycodone (common brand names include Oxycontin and Percocet) and hydrocodone (Vicodin); sedatives such as alprazolam; and stimulants (Adderall). The DEA warns that pills purchased outside of a licensed pharmacy are illegal, dangerous and potentially lethal. For more information, please visit www.dea.gov/onepill.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Brian M. Clark Special Agent in Charge - Los Angeles
@dealosangeles
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster